Institut National De La Sante Et De La Recherche Medicale
- Address
- lock Available on a paid plan
Metabolism and Type 1 Diabetes Research
At Institut National De La Sante Et De La Recherche Medicale, clinical research in metabolism focuses on preserving beta-cell function in adults living with type 1 diabetes mellitus. These studies are designed to explore whether a new therapy can help maintain the body’s own insulin-producing capacity over time.
- Evaluation of type 1 diabetes and its impact on insulin-producing cells
- Assessment of beta-cell preservation as a treatment goal
- Use of C-peptide responses to understand treatment effect
The trials at this Paris site are centered on testing the effectiveness of Verapamil SR as a potential way to support long-term pancreatic function in people with newly diagnosed or established diabetes mellitus.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institut National De La Sante Et De La Recherche Medicale
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Verapamil Hydrochloride Therapy in Type 1 Diabetes Mellitus: A Multi-Center Study on Beta-Cell Function Preservation | Medical University Of Graz | Phase II | Not Recruiting | Nov 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Verapamil Hydrochloride | 1 | Unknown | 2024-11-21 | 2024-11-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.